Effect of low-dose rituximab treatment on autoimmune nodopathy with anti-contactin 1 antibody

BACKGROUND: Autoimmune nodopathy with anti-contactin-1 (CNTN1) responds well to rituximab instead of traditional therapies. Although a low-dose rituximab regimen was administered to patients with other autoimmune diseases, such as myasthenia gravis and neuromyelitis optica spectrum disorders, and sa...

Descripción completa

Detalles Bibliográficos
Autores principales: Hou, Ying, Zhang, Chao, Yu, Xiaolin, Wang, Wenqing, Zhang, Dong, Bai, Yunfei, Yan, Chuanzhu, Ma, Lin, Li, Anning, Ji, Jian, Cao, Lili, Wang, Qinzhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362773/
https://www.ncbi.nlm.nih.gov/pubmed/35958552
http://dx.doi.org/10.3389/fimmu.2022.939062

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9362773/
https://www.ncbi.nlm.nih.gov/pubmed/35958552
http://dx.doi.org/10.3389/fimmu.2022.939062

Ejemplares similares